Erweiterte Suche
Nachrichten (105)
Insiders
Herr Mathieu O. Floreani ist Vorstandsvorsitzender & CEO der Synlab AG, Co-Geschäftsführer der LS Medizin Service GmbH, Group Chief Executive Officer der SYNLAB International GmbH und Co-Geschäftsführer des Medizinischen Versorgungszentrums SYNLAB Leverkusen GmbH. Er ist Mitglied des Verwaltungsrats von Synlab Diagnsticos Globales SA, ALcontrol Group Ltd. und Labco UK Group Ltd. sowie von SYNLAB Ltd. Herr Floreani war zuvor als President, Chief Executive Officer & Director bei DHL Global Forwarding North America und als Managing Director bei SYNLAB Medizinisches Versorgungszentrum Stuttgart GmbH tätig.
Mr. Patrick Floreani, CFA MBA, is a Managing Director & Chief Investment Officer at WealthBridge Investment Counsel, Inc. He is also primarily responsible for the equity portion of client portfolios.
Mr. Floreani was previously employed as a Chief Investment Officer by Société Générale (Canada) and a Partner & Portfolio Manager by Canadian Wealth Management Corp.
He is a graduate of the University of Alberta.
After graduating with a Bachelor of Science degree, He then obtained his Master of Business Administration degree, also from the University of Alberta.
He obtained his Chartered Financial Analyst charter in 1998.
Zaz Floreani is currently a Partner at Firstmile Ventures LLC.
Previously, Zaz held positions as Director-Business Development at AVP Management Services, Inc., Principal at Genesis Global Trading, Inc., and Principal at Next Coast Ventures LLC.
Zaz has an undergraduate degree from the University of California, Los Angeles, and graduate degrees, including an MBA, from The University of Texas at Austin and McCombs School of Business.
Wayne Floreani currently works as a Director at The Canada-Africa Chamber of Business.
Keine Ergebnisse zu dieser Suche
- Börse
- Erweiterte Suche
- Mathieu Floreani